High-Efficiency Transduction of Human Hepatoblastoma and Hepatocellular Carcinoma Cells by the Wild-Type and the Tyrosine-Mutant AAV3 Serotype Vectors

被引:0
|
作者
Glushakova, Lyudmyla G. [1 ]
Lisankie, Matthew J. [1 ]
Eruslanov, Eugeniy B. [1 ]
Ojano-Dirain, Carolyn [1 ]
Zolotukhin, Irene [1 ]
Liu, Chen [1 ]
Srivastava, Arun [1 ]
Stacpoole, Peter W. [1 ]
机构
[1] Univ Florida, Coll Med, Gainesville, FL USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:S179 / S179
页数:1
相关论文
共 22 条
  • [1] High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors
    Petrs-Silva, Hilda
    Dinculescu, Astra
    Li, Qiuhong
    Min, Seok-Hong
    Chiodo, Vince
    Pang, Ji-Jing
    Zhong, Li
    Zolotukhin, Sergei
    Srivastava, Arun
    Lewin, Alfred S.
    Hauswirth, William W.
    MOLECULAR THERAPY, 2009, 17 (03) : 463 - 471
  • [2] Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells
    B Cheng
    C Ling
    Y Dai
    Y Lu
    L G Glushakova
    S W Y Gee
    K E McGoogan
    G V Aslanidi
    M Park
    P W Stacpoole
    D Siemann
    C Liu
    A Srivastava
    C Ling
    Gene Therapy, 2012, 19 : 375 - 384
  • [3] Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells
    Cheng, B.
    Ling, C.
    Dai, Y.
    Lu, Y.
    Glushakova, L. G.
    Gee, S. W. Y.
    McGoogan, K. E.
    Aslanidi, G. V.
    Park, M.
    Stacpoole, P. W.
    Siemann, D.
    Liu, C.
    Srivastava, A.
    Ling, C.
    GENE THERAPY, 2012, 19 (04) : 375 - 384
  • [4] High-Efficiency Transduction of Fibroblasts and Mesenchymal Stem Cells by Tyrosine-Mutant AAV2 Vectors for Their Potential Use in Cellular Therapy
    Li, Mengxin
    Jayandharan, Giridhara R.
    Li, Baozheng
    Ling, Chen
    Ma, Wenqin
    Srivastava, Arun
    Zhong, Li
    HUMAN GENE THERAPY, 2010, 21 (11) : 1527 - 1543
  • [5] Critical Requirement of a Cellular Chaperone Protein, FKBP52, for Intracellular Trafficking and Nuclear Transport of Tyrosine-Mutant AAV2 Vectors for High-Efficiency Transduction of Murine Embryo Fibroblasts
    Zhong, Li
    Li, Mengxin
    Li, Baozheng
    Srivastava, Arun
    MOLECULAR THERAPY, 2009, 17 : S36 - S37
  • [6] High-Efficiency Transduction of Primary Murine Bone Marrow-Derived Mesenchymal Stem Cells by Capsid Tyrosine- Mutant AAV2 Vectors
    Li, Mengxin
    Li, Baozheng
    Zhong, Li
    MOLECULAR THERAPY, 2009, 17 : S179 - S179
  • [7] High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
    Ling, Chen
    Lu, Yuan
    Cheng, Binbin
    McGoogan, Katherine E.
    Gee, Samantha W. Y.
    Ma, Wenqin
    Li, Baozheng
    Aslanidi, George V.
    Srivastava, Arun
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2011, (49):
  • [8] High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors
    Aslanidi, George V.
    Rivers, Angela E.
    Ortiz, Luis
    Govindasamy, Lakshmanan
    Ling, Chen
    Jayandharan, Giridhara R.
    Zolotukhin, Sergei
    Agbandje-McKenna, Mavis
    Srivastava, Arun
    VACCINE, 2012, 30 (26) : 3908 - 3917
  • [9] High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
    Song, Liujiang
    Li, Xiaomiao
    Jayandharan, Giridhara R.
    Wang, Yuan
    Aslanidi, George V.
    Ling, Chen
    Zhong, Li
    Gao, Guangping
    Yoder, Mervin C.
    Ling, Changquan
    Tan, Mengqun
    Srivastava, Arun
    PLOS ONE, 2013, 8 (03):
  • [10] High-Efficiency Transduction of Primary Human CD34+ Hematopoietic Stem/Progenitor Cells by AAV6 Serotype Vectors: Strategies for Overcoming Donor Variation and Implications in Genome Editing
    Yin, Zifei
    Bukhai, Kanit
    Aslanidi, George
    Ling, Chen
    Tan, Mengqun
    Yoder, Mervin
    Leboulch, Philippe
    Payen, Emmanuel
    Srivastava, Arun
    MOLECULAR THERAPY, 2016, 24 : S5 - S6